Anti-SARS-CoV-2 IgA (S1 RBD) ELISA Assay

The Anti-SARS-CoV-2 IgA (S1 RBD) ELISA Assay is for Research Use Only and not for use in diagnostic procedures

Size: 1×96 wells
Incubation Time: 2 hours 40 minutes
Sample Type: Serum and Plasma
Sample Size: 100 µl

Assay is manufactured in Germany by Mediagnost
Controls Included

Assay Principle

The Anti-SARS-CoV-2 IgA ELISA is a two-step enzyme-linked immunosorbent assay. Wells of a 96-well microtiter plate are coated with recombinant SARS-CoV-2-S1 Receptor Binding Domain (RBD). After addition of human serum or plasma samples anti-S1 IgA antibodies from the sample bind to the immobilized antigen during a two hours incubation followed by several washing steps in order to remove unbound components. The bound anti-SARS-CoV-2 IgA antibodies are detected by incubation with horseradish peroxidase (HRP)-conjugated anti-human IgA for 30 minutes. Subsequently, a HRP substrate solution containing 3,3’,5,5’-Tetramethylbenzidine (TMB) is added resulting in the formation of a blue colour. The reaction is terminated by the addition of 0.2 M H2SO4 changing the blue colour into yellow signals which are measured by an absorbance microtiter plate reader at 450 nm. The extinction increases with the amount of the captured antibodies directed against SARS-CoV-2-S1 (RBD) from the patient’s sera.

Related Products

Coronavirus COVID-19 IgG ELISA Assay
Anti-SARS-CoV-2 (S1, S2, N) IgG ELISA Assay Kit
Anti-SARS-CoV-2 S1 (RBD) IgG ELISA Assay

EagleBio在人类中，冠状病毒会引起呼吸道感染。冠状病毒由几种蛋白质组成，包括刺突（S），包膜（E），膜（M）和核衣壳（N）。结果表明，刺突蛋白与血管紧张素转化酶2（ACE2）受体保持足够的亲和力，可将其用作细胞进入的机制。人们主要认为冠状病毒在人与人之间的传播是通过打喷嚏和咳嗽产生的呼吸道飞沫在亲密接触者之间发生的。IgG是响应抗原产生的最丰富的免疫球蛋白，在长期暴露后会保持在体内。Eagle Biosciences仅提供最优质的测定以满足您的需求，并在这些艰难的时期内为您提供最佳的客户服务。